Baheal Sinovate
Beijing Baheal Chengchuang Pharmaceutical Research and Development Co., Ltd. (Baheal Sinovate) is a wholly-owned subsidiary of Baheal Pharma Group. Operating as the Group’s dedicated medical innovation incubation platform, Baheal Sinovate is committed to nurturing original innovations that can truly optimize medical scenarios. Through allocating comprehensive industrial resources, it advances the development and milestone breakthroughs of early-stage innovation pipelines to create pharmaceutical technologies, products and integrated solutions with independent intellectual property rights, thereby steadily advancing the evolution of China’s biopharmaceutical and healthcare sector.

